1. DTIC (NSC-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574) and hydroxyurea (NSC-32065);Carter;Cancer Treat Rep,1976
2. DTIC and combination therapy for melanoma. II. Escalating schedules of DTIC with BCNU, CCNU, and vincristine;Hill;Cancer Treat Rep,1979
3. Evaluation of CCNU (NSC-79037) used for the prevention of CNS involvement in Burkitt’s lymphoma;Ziegler;Cancer Chemother Rep,1975
4. Secondary leukemia following treatment of Hodgkin’s disease: Ultrastructural and cytogenetic data in two cases with a review of the literature;Yahalom;Am J Clin Pathol,1983
5. Triazene metabolism. IV. Derivatives of hydroxymethyltriazenes;Cameron;Anticancer Drug Des,1985